<DOC>
	<DOCNO>NCT00633334</DOCNO>
	<brief_summary>Therapies involve immune system already show great promise early clinical trial treatment renal cell carcinoma melanoma . One great challenge face field extend finding cancer . Little currently understand nature immune response common gastrointestinal cancer . The first goal proposal collect blood tissue sample patient early late stage gastrointestinal cancer . These sample evaluate good understand immune response two cancer . The second goal proposal evaluate specimens patient change genetic marker correlate presence cancer . The information gather study directly enhance ability design , conduct monitor novel immunotherapeutic protocol treatment patient gastrointestinal cancer .</brief_summary>
	<brief_title>Development Early Detection Signs Gastrointestinal Cancer</brief_title>
	<detailed_description>The first goal proposal collect cell peripheral blood , tumor drain lymph node tumor infiltrate lymphocyte patient early late stage gastrointestinal cancer . These sample evaluate variety immunological assay well understand immune response two cancer . The second goal proposal evaluate use novel proteomic , cellomic , genomic technique serum peripheral blood lymphocytes patient protein , cellular change genetic marker correlate presence cancer . The information gather study directly enhance ability design , conduct monitor novel immunotherapeutic protocol treatment patient gastrointestinal cancer .</detailed_description>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>histologically confirm GI malignancy suspect GI malignancy high risk individual assess physician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cancer</keyword>
	<keyword>GI</keyword>
	<keyword>Tumor</keyword>
	<keyword>Gastrointestinal</keyword>
	<keyword>high risk</keyword>
</DOC>